Development of a Computer Assisted Survivor Screening For Adult Survivors of Childhood Cancer

Development of a Computer Assisted Survivor Screening For Adult Survivors of Childhood Cancer


Lead sponsor: Memorial Sloan Kettering Cancer Center

Source Memorial Sloan Kettering Cancer Center
Brief Summary

This study will compare two ways of having people respond to a questionnaire about health and emotional well-being: on a computer and with paper and pencil. We will see how long it takes using both methods. We will also ask you how you feel about using a computer to answer the questions.

Detailed Description

To determine feasibility of using the Computer Assisted Survivor Screening (CASS) as a routine screening measure for the survivor population. Specifically, to determine patient acceptance, time to completion, and burden associated with the CASS. To examine the potential utility of the CASS as a routine screening measure in the survivor population. To validate the CASS against the SCL-90-R screening measure. Calculate the sensitivity,specificity, positive and negative predictive values, diagnostic agreement and ROC curve of the CASS compared to the SCL-90. Determine the optimal cut-off scores to optimize agreement between the CASS and the SCL-90.

Overall Status Completed
Start Date August 2004
Completion Date July 2008
Primary Completion Date July 2008
Study Type Observational
Enrollment 100

Sampling method: Non-Probability Sample


Inclusion Criteria:

- Currently at least 18 years of age and not older than 49 years of age

- Diagnosed with first malignancy before the age of 22

- Completed all cancer treatment at least three years prior

- Able to complete the survey instruments in English

- Scheduled for a routine off-treatment follow-up oncology appointment

- Currently disease-free and not receiving any cancer treatment

Exclusion Criteria:

- History of a central nervous system tumor

- A sensory or cognitive impairment that would interfere with completion of the survey

- Currently undergoing treatment by a psychiatrist or psychologist (ie., currently receiving psychotherapy and/or psychotropic medications, as per self-report)

Gender: All

Minimum age: 18 Years

Maximum age: 49 Years

Healthy volunteers: No

Overall Official
Last Name Role Affiliation
Jennifer Ford, PhD Principal Investigator Memorial Sloan Kettering Cancer Center
Memorial Sloan-Kettering Cancer Center
Location Countries

United States

Verification Date

July 2008

Responsible Party

Name title: Jennifer Ford, PhD

Organization: Memorial Sloan-Kettering Cancer Center

Has Expanded Access No
Study Design Info

Observational model: Case-Only

Time perspective: Prospective